Skip to main navigation Skip to search Skip to main content

Response to the article by Narla et al “Management of inadequate response and adverse effects to dupilumab in atopic dermatitis”

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)e65-e66
JournalJournal of the American Academy of Dermatology
Volume88
DOIs
Publication statusPublished - 2023

Keywords

  • atopic dermatitis
  • combination therapy
  • dupilumab

Cite this